See more : Kaiser Group Holdings, Inc. (KGHI) Income Statement Analysis – Financial Results
Complete financial analysis of Opto Circuits (India) Limited (OPTOCIRCUI.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Opto Circuits (India) Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- Saeron Automotive Corporation (075180.KS) Income Statement Analysis – Financial Results
- Exelon Corporation (PEO.DE) Income Statement Analysis – Financial Results
- Xi’an Kingfar Ppty Svcs Co Ltd (1354.HK) Income Statement Analysis – Financial Results
- WiSA Technologies, Inc. (WISA) Income Statement Analysis – Financial Results
- Roku, Inc. (ROKU) Income Statement Analysis – Financial Results
Opto Circuits (India) Limited (OPTOCIRCUI.NS)
About Opto Circuits (India) Limited
Opto Circuits (India) Limited manufactures and trades in invasive and non-invasive medical equipment in India and internationally. It operates through Sensors, Monitors, and Others segments. The company offers data management and connectivity products that connect to hospital information systems, electronic medical records, and other information systems; defibrillation systems to detect and identify arrhythmias; non-invasive vascular diagnostic systems to detect peripheral arterial disease; and respiratory and anesthesia monitoring products to identify and quantify inspired and expired CO2, O2, and N2O. It also provides non-invasive reusable and disposable sensors, extension and adapter cables, neo wraps, Y tapes, and Water Traps and ComfortCuffs, as well as batteries, defibrillation pads, electrodes, doppler probes, and other accessories and consumables; veterinary care products to diagnose, measure, and monitor parameters on animals; and vital signs patient monitoring equipment to measure and display a patient's vital signs. In addition, the company offers cardiac stents; catheters and related disposable products in the fields of urology, gastroenterology, and gynecology; PTA balloons to decrease the stimulus of chronic inflammation and the trigger for late thrombosis; and orthopedic implants, as well as surgical consumables, such as endernails and wound suction drainage systems. Further, it offers education and training, technical support, and professional services, as well as turnkey solutions in specialty ambulances, modular operation theatres, and cathlabs; and services in information technology, global positioning systems, and electronic design automation. The company serves physicians, general practitioners and specialists, clinics, and hospitals. Opto Circuits (India) Limited was founded in 1992 and is headquartered in Bengaluru, India.
Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 1.81B | 2.56B | 2.28B | 2.15B | 3.13B | 11.87B | 14.08B | 23.99B | 23.57B | 15.86B | 10.78B | 8.19B | 4.68B | 2.52B | 1.40B | 1.23B |
Cost of Revenue | 0.00 | 774.83M | 1.19B | 1.04B | 992.53M | 1.71B | 6.51B | 8.05B | 15.36B | 12.95B | 9.35B | 5.99B | 4.75B | 2.78B | 1.33B | 733.01M | 743.41M |
Gross Profit | 0.00 | 1.04B | 1.36B | 1.25B | 1.16B | 1.42B | 5.36B | 6.03B | 8.63B | 10.62B | 6.50B | 4.79B | 3.43B | 1.90B | 1.18B | 664.79M | 484.94M |
Gross Profit Ratio | 0.00% | 57.24% | 53.25% | 54.52% | 53.90% | 45.37% | 45.14% | 42.84% | 35.97% | 45.05% | 41.02% | 44.44% | 41.93% | 40.55% | 47.00% | 47.56% | 39.48% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.94M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 266.71M | 194.97M | 243.02M | 140.00M | 201.57M | 0.00 | 0.00 | 656.29M | 1.73B | 2.46B | 1.11B | 408.20M | 263.93M | 170.13M | 104.82M | 91.39M |
Selling & Marketing | 0.00 | 47.37M | 52.08M | 53.19M | 50.53M | 119.92M | 0.00 | 0.00 | 1.16B | 512.39M | 0.00 | 0.00 | 113.36M | 58.74M | 55.40M | 30.55M | 32.06M |
SG&A | 0.00 | 314.08M | 247.05M | 296.21M | 190.53M | 321.49M | 0.00 | 0.00 | 1.81B | 2.24B | 2.46B | 1.11B | 521.56M | 322.68M | 225.52M | 135.37M | 123.45M |
Other Expenses | 0.00 | -3.28B | 576.11M | 543.32M | 741.69M | 1.20B | 45.56M | 64.07M | 57.13M | 58.80M | 203.65M | 353.84M | 574.86M | 295.60M | 185.32M | 138.19M | 114.11M |
Operating Expenses | 0.00 | -2.96B | 823.16M | 839.53M | 932.22M | 1.52B | 3.71B | 4.15B | 5.53B | 4.92B | 2.67B | 1.47B | 1.10B | 618.28M | 410.85M | 273.56M | 237.56M |
Cost & Expenses | 0.00 | -2.19B | 2.02B | 1.88B | 1.92B | 3.23B | 10.23B | 12.20B | 20.90B | 17.87B | 12.02B | 7.45B | 5.85B | 3.40B | 1.74B | 1.01B | 980.97M |
Interest Income | 0.00 | 43.61M | 0.00 | 2.26M | 1.74M | 51.07M | 4.95M | 4.75M | 0.00 | 7.81M | 0.00 | 0.00 | 20.61M | 23.35M | 26.55M | 4.50M | 2.99M |
Interest Expense | 0.00 | 279.00M | 22.11M | 44.60M | 157.61M | 417.46M | 1.27B | 687.38M | 894.10M | 591.98M | -101.32M | 870.36M | 537.02M | 108.67M | 74.09M | 52.25M | 36.92M |
Depreciation & Amortization | 206.30K | 55.41M | 107.87M | -842.93M | 3.34B | 1.41B | -275.77M | 1.25B | 906.76M | -272.87M | 704.99M | -169.59M | 449.07M | 80.66M | 48.91M | 23.22M | 17.83M |
EBITDA | 0.00 | 4.10B | 675.48M | 518.24M | 3.55B | 1.51B | 2.47B | 3.07B | 4.18B | 6.31B | 4.54B | 3.60B | 3.17B | 1.54B | 877.71M | 439.56M | 261.10M |
EBITDA Ratio | 0.00% | 226.53% | 26.43% | 22.69% | 165.05% | 48.34% | 20.83% | 21.81% | 17.41% | 26.76% | 28.63% | 33.42% | 38.68% | 32.92% | 34.89% | 31.45% | 21.26% |
Operating Income | 0.00 | 4.05B | 567.61M | 1.36B | 218.20M | 98.01M | 2.75B | 1.82B | 3.27B | 6.58B | 3.84B | 3.77B | 2.72B | 1.46B | 828.79M | 416.33M | 243.26M |
Operating Income Ratio | 0.00% | 223.47% | 22.21% | 59.61% | 10.13% | 3.13% | 23.15% | 12.90% | 13.63% | 27.92% | 24.19% | 35.00% | 33.19% | 31.20% | 32.94% | 29.78% | 19.80% |
Total Other Income/Expenses | 0.00 | -17.84B | -29.67M | -996.28M | -5.29B | -105.92M | -4.30B | -696.70M | 583.59M | -1.42B | 101.32M | -870.36M | -549.20M | -108.81M | -74.16M | -20.66M | -36.92M |
Income Before Tax | 0.00 | -13.79B | 537.94M | 364.88M | -5.07B | -7.91M | -1.55B | 1.12B | 3.85B | 5.16B | 3.94B | 2.90B | 2.17B | 1.35B | 754.64M | 395.67M | 206.34M |
Income Before Tax Ratio | 0.00% | -761.26% | 21.05% | 15.98% | -235.72% | -0.25% | -13.09% | 7.96% | 16.07% | 21.90% | 24.83% | 26.92% | 26.48% | 28.87% | 30.00% | 28.31% | 16.80% |
Income Tax Expense | 0.00 | 1.72M | 21.85M | 8.99M | 8.10M | 11.49M | 17.13M | 219.74M | 31.22M | -571.64M | 250.89M | 296.37M | 74.96M | 38.40M | 22.09M | 9.53M | 5.71M |
Net Income | 0.00 | -13.80B | 513.77M | 346.22M | -5.08B | -19.40M | -1.56B | 909.72M | 3.80B | 5.73B | 3.69B | 2.60B | 2.09B | 1.31B | 732.54M | 386.14M | 200.64M |
Net Income Ratio | 0.00% | -761.35% | 20.10% | 15.16% | -236.10% | -0.62% | -13.17% | 6.46% | 15.83% | 24.33% | 23.24% | 24.17% | 25.57% | 28.05% | 29.12% | 27.63% | 16.33% |
EPS | 0.00 | -45.89 | 1.77 | 1.34 | -20.98 | -0.08 | -6.45 | 3.75 | 15.67 | 23.60 | 15.16 | 10.73 | 8.78 | 6.22 | 3.58 | 2.17 | 1.13 |
EPS Diluted | 0.00 | -45.89 | 1.77 | 1.34 | -20.98 | -0.08 | -6.45 | 3.75 | 15.67 | 23.60 | 15.16 | 10.73 | 8.78 | 6.17 | 3.53 | 2.17 | 1.13 |
Weighted Avg Shares Out | 300.44M | 300.63M | 289.98M | 258.29M | 242.32M | 242.32M | 242.32M | 242.32M | 242.32M | 242.32M | 186.40M | 242.67M | 209.91M | 208.12M | 204.14M | 177.74M | 177.74M |
Weighted Avg Shares Out (Dil) | 300.44M | 300.63M | 289.98M | 258.29M | 242.32M | 242.32M | 242.32M | 242.32M | 242.32M | 242.32M | 186.40M | 242.67M | 209.91M | 211.77M | 207.02M | 177.74M | 177.74M |
Source: https://incomestatements.info
Category: Stock Reports